Thornhill is internationally recognized as a leader in the precise control and management of arterial blood gases. This expertise has allowed it to develop and supply a range of novel, IP protected, portable, medical systems that are able to provide critical life support functions to those deployed in challenging circumstances. Thornhill Medical delivers unique and valuable solutions that include 1) MOVES® SLC™: a portable life support for casualty care during patient transport, in field hospitals and forward surgical suites; 2) ClearMateTM: immediate and effective treatment for carbon monoxide poisoning; 3) MADMTM: mobile anesthesia; and 4) RespirAct™ RA-MR: an investigational tool used in diagnostic procedures which measure vascular reactivity. Thornhill differentiates itself in this market via its superior understanding of the utilization of arterial blood gases, thus eliminating, or substantially reducing the bulk, weight, cost and logistic burdens of other products, while optimizing patient outcomes. The efficacy of its solutions is recognized globally, with the United States Marine Corps, the Government of Ontario and the Federal Government of Canada being notable customers.